Connor, Clark & Lunn Investment Management Ltd.
Position in ACAD — Acadia Pharmaceuticals Inc
CIK 1596800
VANCOUVER, A1
Position in ACAD
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$6,550,338
-$8,967,343 QoQ
Shares Held
294,265
-49.3% QoQ
Ownership
0.172%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Connor, Clark & Lunn Investment Management Ltd. holds $703,286,486 across 100 Biotechnology names. ACAD ranks #26 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
251,711 | $112,399,029 | |
| 2 | IONS |
Ionis Pharmaceuticals Inc
|
874,089 | $65,635,343 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
836,981 | $52,478,708 | |
| 4 | MIRM |
Mirum Pharmaceuticals, Inc.
|
479,476 | $44,293,992 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
32,164 | $24,851,192 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
134,792 | $22,782,543 | |
| 7 | SRPT |
Sarepta Therapeutics, Inc.
|
1,019,951 | $22,194,133 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
384,681 | $20,280,382 |
All Filings in ACAD
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $6,550,338 | 294,265 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $15,517,681 | 580,969 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $14,262,866 | 668,363 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $13,857,603 | 642,448 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $9,505,255 | 572,261 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $12,582,888 | 685,716 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $14,959,587 | 972,665 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $20,370,057 | 1,253,542 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $15,832,968 | 856,299 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $19,643,393 | 627,384 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $13,201,493 | 633,469 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $12,827,164 | 535,581 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $9,375,709 | 498,178 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $7,793,572 | 489,546 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $8,342,307 | 509,921 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,134,860 | 151,516 | Shares | Sole | 2022-08-05 | |
| 2022-03-31 | $1,395,919 | 57,635 | Shares | Sole | 2022-05-12 | |
| No filing history on record for this holder in this stock. | ||||||